Monogram Orthopaedics announces conversion of Series D Preferred Stock

Monogram Technologies announced the mandatory conversion of all outstanding shares of 8.00% Series D Convertible Cumulative Preferred Stock that were issued in connection with the Company’s offering that closed on October 1, 2024. During the Offering, the Company issued and sold units, with each unit consisting of one share of the Company’s Series D Preferred Stock and one common stock purchase warrant to purchase one share of the Company’s common stock, $0.001 par value per share. On July 7, 2025, the Company sent a notice of mandatory conversion to all holders of Series D Preferred Stock notifying such holders that, in accordance with Section 6(a) of the Certificate of Designation of Preferences, Rights and Limitations of the Series D Preferred Stock, the closing price of the Common Stock closed at or above $2.8125 per share for ten consecutive trading days ending and including July 7, 2025, thereby triggering a Mandatory Conversion pursuant to Section 6(a) of the Certificate of Designation. Such conversion shall be effective as of July 14, 2025.